from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3646c/topA

LFCtreatmentdescriptionclass of inhibitor

-0.850

Amikacinug/mL Amikacintranslation

0.214

Cap5-10ug/mL Capreomycintranslation

-1.048

Rox10-50 ug/mL Roxithromycintranslation

0.775

SM2-5 ug/mL Streptomycintranslation

-1.222

Tet5-10 ug/mL Tetracyclinetranslation

-1.049

Rif0.2-5ug/mL Rifampicintranscription

-0.185

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.044

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.348

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.912

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.183

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.138

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.478

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.776

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.547

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.004

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.352

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.743

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.302

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.497

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.727

KCN5-20 ug/mL Potassium cyaniderespiration

-0.392

NaN30.2-2 mM Sodium aziderespiration

0.715

Nigericin50 uM Nigericinrespiration

-0.870

TRC10-150 ug/mL Triclosanrespiration

-1.667

TRZ10-25 ug/mL Thioridazinerespiration

1.094

Valinomycin0.5-10 uM Valinomycinrespiration

0.545

ZnSO42 mM ZnSO4respiration

-0.036

menadione6-10 ug/mL Menadionerespiration

0.023

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.540

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.171

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.717

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.518

NRP_1Non-replicating persistence stage 1dosRassociated

0.961

Amp0.2mg/mL AmpicillincellWall

0.300

Cephalexin20-100 ug/mL CephalexincellWall

0.792

Cerulenin0.32-5 ug/mL CerulenincellWall

0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.288

EMB10-20 ug/mL EthambutolcellWall

0.287

Eta12-40 ug/mL EthionamidecellWall

0.138

INH0.2-0.4 ug/mL IsoniazidcellWall

0.045

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.231

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.580

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.168

BZA0.12 mg/mL BenzamidearomaticAmides

1.111

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.968

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.043

H2O24 mM hydrogen peroxideDNAdamaging

0.054

Levo10 ug/mL LevofloxacinDNAdamaging

0.707

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.509

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.183

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.383

UVUV-irradiationDNAdamaging

-1.751

ARP41-4 ug/mL Antitubercular compound ARP4?

0.584

Antimycin12.5-50 ug/mL Antimycin A?

0.401

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.373

PA_110-50 ug/mL Antitubercular compound PA-1?

0.525

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.060

PA8240.2-2 ug/mL PA-824?

-0.830

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.010

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.887

Verapamil50 uM Verapamil?

0.055

mercaptoethanol2 mM 2-Mercaptoethanol?

0.775

methoxatin10-20 ug/mL Methoxatin?